Publications by authors named "Ole Graff"

Claim this Profile
U
Using AI-generated digital twins to boost clinical trial efficiency in Alzheimer's disease.
Deli Wang, Hana Florian, Shau-Yu Lynch, Weining Robieson, Run Zhuang, Ole Graff

Alzheimers Dement (N Y)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.
Jennifer S Gewandter, Robert H Dworkin, Dennis C Turk, John T Farrar, Roger B Fillingim, Ole X Graff

Pain Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the probability of pharmacological success to inform compound progression decisions.
Xuan Zhou, Ole Graff, Chao Chen

PLoS One· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-risk tradeoff preferences for chronic hand eczema treatments.
A Brett Hauber, Ateesha F Mohamed, Juan Marcos Gonzalez, Angelyn Otteson Fairchild, Susan C Zelt, Ole Graff

J Dermatolog Treat· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.
Marc Morris, Lorrie Schifano, Regan Fong, Ole Graff

J Dermatolog Treat· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.
Jennifer S Gewandter, Robert H Dworkin, Dennis C Turk, John T Farrar, Roger B Fillingim, Ole X Graff

Pain· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Joseph F Fowler, Ole Graff, Abbas G Hamedani

J Drugs Dermatol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2a, randomized, crossover trial of gabapentin enacarbil for the treatment of postherpetic neuralgia in gabapentin inadequate responders.
R Norman Harden, Roy Freeman, Michelle Rainka, Lixin Zhang, Chris Bell, Ole Graff

Pain Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy.
Richard Rauck, Clare W Makumi, Sherwyn Schwartz, Ole Graff, Guy Meno-Tetang

Pain Pract· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748).
Lixin Zhang, Michelle Rainka, Roy Freeman, R Norman Harden, Christopher F Bell, Ole Graff

J Pain· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.
Susan Learned, Ole Graff, Suraja Roychowdhury, Rachel Moate, K Ranga Krishnan

J Psychopharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.
David H Miller, Thomas Weber, Richard Grove, Claire Wardell, Joseph Horrigan, Ole Graff

Lancet Neurol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD.
Timothy E Wilens, Thorsten Klint, Lenard Adler, Scott West, Keith Wesnes, Ole Graff

Behav Brain Funct· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis